[6] This specificity is unique among fat loss peptides
| Protocol Type | Tirzepatide Dose | 5-Amino-1MQ Dose | Administration Frequency | Expected Mechanism | Typical Observation Window | Professional Assessment | ||||||| | Tirzepatide Monotherapy | 2.515mg weekly (titrated) | None | Weekly subcutaneous injection | GLP-1/GIP receptor agonism reduces appetite and slows gastric emptying | 1220 weeks to plateau | Proven efficacy in human trials
Because there are no long-term human studies, the safety of these peptides is unknown, meaning they could be a waste of money or cause hidden damage to your body over time
Published findings concerning body composition, glucose regulation, liver pathology and muscle function come from laboratory and animal studies rather than established human clinical trials
While there is ample evidence that B12, as an essential vitamin, has numerous health benefits, there is no evidence that B12 shots have greater benefit than a B12 supplement in pill form
Hypothalamic-pituitary-adrenal axis signaling investigated for pathway modulation activity in vitro
